ProPublica

ProPublica Publishes Unreleased Data on the Origins of Generic Prescription Drugs

ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. ProPublica on Friday published never-before-released data ...
STAT

Supreme Court agrees to review ‘skinny labeling’ and generic drug access

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...
PBS

Investigation raises concerns about lack of FDA quality testing for generic drugs

But a ProPublic investigation found that the FDA rarely tests the quality of generic drugs, many of them manufactured overseas. National reporter Debbie Cenziper of ProPublica was one of the authors ...
ProPublica

The FDA Often Doesn’t Test Generic Drugs for Quality Concerns, So ProPublica Did

ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. These highlights were written by the reporters and editors ...
The Shreveport Times

Generic Vyvanse may not be working like it should. What to know about nationwide recall

Vyvanse, or its generic counterpart lisdexamfetamine dimesylate, is prescribed to treat ADHD in adults, and children six years of age or older, as well as moderate to sever binge eating disorder (BED) ...
Monthly Prescribing Reference

FDA Approves First Generic Version of Premarin Tablets

The generic product is now available nationwide in strengths of 0.3mg, 0.45mg, 0.625mg, 0.9mg, and 1.25mg. The Food and Drug Administration (FDA) has approved the first generic version of Premarin ® ...
Bloomberg L.P.

Cigna Unit Sells Generic Drugs at Higher Prices, Report Says

A little-known Cigna Group subsidiary that sells generic drugs charges prices that skew higher than many competing suppliers, according to a new analysis that raises questions about the company’s role ...
The New York Times

This Closed Factory Shows How Hard Reviving Drug Manufacturing Will Be

President Trump wants pharmaceutical production to return to the United States. A shuttered factory in Louisiana shows how hard that will be for generic medicines. Dr. Reddy’s, an Indian generic ...
Law

Federal Judge Denies Big Pharma's Motion to Shut Down Multistate Dermatological Generic Drug Price Fixing Lawsuit

Federal Judge Denies Big Pharma's Motion to Shut Down Multistate Dermatological Generic Drug Price Fixing Lawsuit "A reasonable juror could find that the defendants’ 'blaming supply,' making ...
The Hill

FDA to streamline approvals of generic biologic drugs

The Food and Drug Administration (FDA) is launching an effort to streamline the approval process for cheaper alternative “biosimilar” versions of biologic drugs as a way to curb health costs. The ...
CNBC

FDA to speed up approvals of generic biologic medicines as Trump targets high drug costs

The Food and Drug Administration said it will take steps to speed up the process of developing generic versions of complex biological drugs, in a bid to increase cheaper competition for expensive ...
STAT

Generic drugmakers seek to thwart a Connecticut law that would cap rising prices

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...